PTPRC and acute myeloid leukemia: This has implications for the present study on the mechanism of drug resistance in AML, i.e., LGALS9 targeting and inhibiting CD45 affects AML chemoresistance through the regulation of immune cell activity in the bone marrow microenvironment.